What is the recommended dosing and duration of Eliquis (apixaban) for postoperative thromboprophylaxis after a nephrectomy, and how should renal function influence the choice of anticoagulant?

Eliquis Post-Nephrectomy: Dosing and Management

For postoperative thromboprophylaxis after nephrectomy, use low-molecular-weight heparin (LMWH) such as enoxaparin 40 mg once daily rather than Eliquis (apixaban), as nephrectomy is not an FDA-approved indication for apixaban and renal function changes post-nephrectomy significantly complicate dosing.

Why LMWH is Preferred Over Apixaban

Nephrectomy creates a unique clinical scenario that makes apixaban problematic:

• FDA labeling does not include nephrectomy: Apixaban is FDA-approved only for thromboprophylaxis after hip or knee replacement surgery at 2.5 mg twice daily, not for general abdominal or urologic surgery 11

• Renal function is unpredictable post-nephrectomy: Studies show that renal function can deteriorate significantly after nephrectomy, with 13% of patients developing GFR <30 mL/min within 90 days 2. Apixaban exposure increases by 44% in severe renal impairment 3, and dose-adjusted concentrations are 3.3-fold higher in patients with GFR <30 mL/min 4

• Guideline-supported approach: ASCO guidelines specifically recommend LMWH (enoxaparin 40 mg once daily or dalteparin 5,000 U once daily) for surgical patients, with prophylaxis continued for at least 7-10 days and extended up to 4 weeks for high-risk patients 55

If Apixaban Must Be Used (Off-Label)

Only consider apixaban if there are compelling contraindications to LMWH and after careful assessment of renal function.

Dosing Protocol:

• Initial postoperative period (first 48-72 hours): Use LMWH or UFH, not apixaban 66

• After hemostasis is established: Consider apixaban 2.5 mg twice daily (the prophylactic dose used in orthopedic surgery) 11

• Duration: 28 days for major cancer surgery, based on emerging evidence from gynecologic oncology 7

Critical Renal Function Monitoring:

Check creatinine clearance (CrCl) using Cockcroft-Gault formula before starting apixaban and weekly for the first month 62:

• CrCl >50 mL/min: Apixaban 2.5 mg twice daily may be used
• CrCl 30-50 mL/min: Exercise extreme caution; consider dose reduction or avoid apixaban entirely
• CrCl <30 mL/min: Contraindicated - apixaban concentrations become supratherapeutic 43

Key Monitoring Points:

1. Baseline assessment: Obtain CrCl before discharge using actual measured creatinine, not estimated GFR
2. Week 1-2: Recheck renal function as this is when deterioration often occurs post-nephrectomy 2
3. Week 3-4: Final assessment before completing prophylaxis
4. Red flags: If CrCl drops below 50 mL/min, immediately switch to alternative prophylaxis or discontinue

Perioperative Management If Patient Already on Apixaban

For patients on chronic apixaban therapy requiring nephrectomy:

Preoperative Discontinuation:

Nephrectomy is a high bleeding risk procedure requiring longer interruption 66:

• CrCl >50 mL/min: Stop apixaban 3 days before surgery (skip 4 doses) 689
• CrCl 30-50 mL/min: Stop apixaban 4 days before surgery (skip 6 doses) 8
• No bridging required: Do not bridge with LMWH unless patient has very high thrombotic risk 66

Postoperative Resumption:

• Wait 48-72 hours after surgery before restarting therapeutic-dose apixaban 68
• Ensure adequate hemostasis before resumption 66
• Consider reduced dose initially: Start with 2.5 mg twice daily for first 2-3 days, then increase to therapeutic dose (5 mg twice daily for most indications) 8
• Reassess renal function before resuming, as nephrectomy will have altered kidney function 62

Common Pitfalls to Avoid

1. Using estimated GFR instead of CrCl: Apixaban dosing is based on Cockcroft-Gault CrCl, not MDRD or CKD-EPI eGFR 63

2. Assuming stable renal function: Post-nephrectomy patients have dynamic renal function that requires serial monitoring 210

3. Starting apixaban too soon: Premature resumption within 24 hours increases bleeding risk in major surgery 8

4. Ignoring drug interactions: P-glycoprotein and CYP3A4 inhibitors increase apixaban levels - avoid or reduce dose by 50% 1

5. Continuing ACE inhibitors/ARBs immediately post-nephrectomy: These may impair compensatory hyperfiltration in the remaining kidney 10

Bottom Line Algorithm

Standard approach: Enoxaparin 40 mg SC once daily starting 6-8 hours postoperatively, continued for 28 days 55

If apixaban considered:

• Wait 48-72 hours post-op
• Confirm CrCl >50 mL/min
• Use 2.5 mg twice daily
• Monitor CrCl weekly
• Duration 28 days
• Switch to LMWH if CrCl drops below 50 mL/min